Elisa Anastasi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisa Anastasi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ahmed A. Hassan
Faculty of Medicine, Cairo University , Cairo , Egypt
1 shared publication Andreas Teubner
Central Animal Facility, CPV, Maastricht University, Maastricht, the Netherlands
1 shared publication- Anil Wipat
Newcastle University, Newcastle Upon Tyne, England
1 shared publication Chien-Yi Hsu
Division of Cardiology and Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan
1 shared publication- Cristian Nogales
Max Perutz Labs, Vienna BioCenter Campus, Department of Structural and Computational Biology, University of Vienna, Vienna, Austria
1 shared publication - Emre Guney
STALICLA Discovery and Data Science Unit, World Trade Center, Moll de Barcelona, Edif Este, 08039 Barcelona, Spain
1 shared publication
Latest Publications
- Open Access
- 10 November 2020
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (11) , e3000885
NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype
Hypertension is the most important cause of death and disability in the elderly. In 9 out of 10 cases, the molecular cause, however, is unknown. One mechanistic hypothesis involves impaired endothelium-dependent vasodilation through reactive oxygen species (ROS) formation. Indeed, ROS forming NADPH oxidase (Nox) genes associate with hypertension, yet target validation has been negative. We re-investigate this association by molecular network analysis and identify NOX5, not present in rodents, as a sole neighbor to human vasodilatory endothelial nitric oxide (NO) signaling. In hypertensive patients, endothelial microparticles indeed contained higher levels of NOX5—but not NOX1, NOX2, or NOX4—with a bimodal distribution correlating with disease severity. Mechanistically, mice expressing human Nox5 in endothelial cells developed—upon aging—severe systolic hypertension and impaired endothelium-dependent vasodilation due to uncoupled NO synthase (NOS). We conclude that NOX5-induced uncoupling of endothelial NOS is a causal mechanism and theragnostic target of an age-related hypertension endotype. Nox5 knock-in (KI) mice represent the first mechanism-based animal model of hypertension.
- 10 November 2020
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (11) , e3000885
Open AccessNOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype
Hypertension is the most important cause of death and disability in the elderly. In 9 out of 10 cases, the molecular cause, however, is unknown. One mechanistic hypothesis involves impaired endothelium-dependent vasodilation through reactive oxygen species (ROS) formation. Indeed, ROS forming NADPH oxidase (Nox) genes associate with hypertension, yet target validation has been negative. We re-investigate this association by molecular network analysis and identify NOX5, not present in rodents, as a sole neighbor to human vasodilatory endothelial nitric oxide (NO) signaling. In hypertensive patients, endothelial microparticles indeed contained higher levels of NOX5—but not NOX1, NOX2, or NOX4—with a bimodal distribution correlating with disease severity. Mechanistically, mice expressing human Nox5 in endothelial cells developed—upon aging—severe systolic hypertension and impaired endothelium-dependent vasodilation due to uncoupled NO synthase (NOS). We conclude that NOX5-induced uncoupling of endothelial NOS is a causal mechanism and theragnostic target of an age-related hypertension endotype. Nox5 knock-in (KI) mice represent the first mechanism-based animal model of hypertension.